Thus RB-012 effectively reduces A549 xenograft growth by a mechanism involving disruption of the oncogenic signaling in these cells, supporting the notion that RB-012 reduces tumor growth by disruption of dimeric 14-3-3 function. The gene discussed is YWHAQ; the disease is neoplasm.